{"id":20942,"date":"2020-09-15T08:00:43","date_gmt":"2020-09-15T06:00:43","guid":{"rendered":"https:\/\/www.satt.fr\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/"},"modified":"2020-09-15T08:00:43","modified_gmt":"2020-09-15T06:00:43","slug":"ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/","title":{"rendered":"Ouest Valorisation entre au capital de GlioCure, start-up issue de l&#8217;universit\u00e9 d&#8217;Angers"},"content":{"rendered":"<p><strong>Ouest Valorisation entre au capital de la start-up angevine GlioCure. Issue de l\u2019universit\u00e9 d\u2019Angers, elle est pionni\u00e8re dans le traitement des tumeurs c\u00e9r\u00e9brales.<\/strong><\/p>\n<p><strong>Depuis de nombreuses ann\u00e9es, Ouest Valorisation et l\u2018universit\u00e9 d\u2019Angers, nouvel actionnaire de la SATT, m\u00e8nent \u00e0 bien des projets \u00e0 forte valeur ajout\u00e9e, notamment dans le domaine de la sant\u00e9. Parmi eux, les projets du laboratoire de Neurobiologie et Transg\u00e9n\u00e8se du Dr Jo\u00ebl Eyer puis celui de la start-up GlioCure.<br \/>\n<\/strong><strong>Depuis l\u2019origine, Ouest Valorisation est associ\u00e9e au d\u00e9veloppement de GlioCure\u00a0: D\u00e9p\u00f4t de brevets, programme de maturation, transfert technologique, accompagnement \u00e0 la cr\u00e9ation d\u2019entreprise. Ce partenariat de longue date se poursuit par l\u2019entr\u00e9e de Ouest Valorisation au capital de la jeune start-up.<\/strong><\/p>\n<p><a href=\"https:\/\/www.ouest-valorisation.fr\/fr\/portfolio\/ouest-valorisation-entre-au-capital-de-gliocure\/\">En savoir plus<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ouest Valorisation entre au capital de la start-up angevine GlioCure. Issue de l\u2019universit\u00e9 d\u2019Angers, elle est pionni\u00e8re dans le traitement des tumeurs c\u00e9r\u00e9brales. Depuis de nombreuses ann\u00e9es, Ouest Valorisation et l\u2018universit\u00e9 d\u2019Angers, nouvel actionnaire de la SATT, m\u00e8nent \u00e0 bien des projets \u00e0 forte valeur ajout\u00e9e, notamment dans le domaine de la sant\u00e9. Parmi eux, [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":20903,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,604],"tags":[],"class_list":["post-20942","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ouest Valorisation entre au capital de GlioCure, start-up issue de l&#039;universit\u00e9 d&#039;Angers - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anne Guedon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/\"},\"author\":{\"name\":\"Anne Guedon\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\"},\"headline\":\"Ouest Valorisation entre au capital de GlioCure, start-up issue de l&#8217;universit\u00e9 d&#8217;Angers\",\"datePublished\":\"2020-09-15T06:00:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/\"},\"wordCount\":151,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg\",\"articleSection\":[\"News\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/\",\"url\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/\",\"name\":\"Ouest Valorisation entre au capital de GlioCure, start-up issue de l'universit\u00e9 d'Angers - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg\",\"datePublished\":\"2020-09-15T06:00:43+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg\",\"width\":3333,\"height\":1859},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ouest Valorisation entre au capital de GlioCure, start-up issue de l&#8217;universit\u00e9 d&#8217;Angers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e\",\"name\":\"Anne Guedon\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/anne\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ouest Valorisation entre au capital de GlioCure, start-up issue de l'universit\u00e9 d'Angers - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/","twitter_misc":{"Written by":"Anne Guedon","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/"},"author":{"name":"Anne Guedon","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e"},"headline":"Ouest Valorisation entre au capital de GlioCure, start-up issue de l&#8217;universit\u00e9 d&#8217;Angers","datePublished":"2020-09-15T06:00:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/"},"wordCount":151,"image":{"@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg","articleSection":["News","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/","url":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/","name":"Ouest Valorisation entre au capital de GlioCure, start-up issue de l'universit\u00e9 d'Angers - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg","datePublished":"2020-09-15T06:00:43+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/09\/Gliocure_entre\u0301e-capital_ouest-valorisation.jpg","width":3333,"height":1859},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/ouest-valorisation-entre-au-capital-de-gliocure-start-up-issue-de-luniversite-dangers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Ouest Valorisation entre au capital de GlioCure, start-up issue de l&#8217;universit\u00e9 d&#8217;Angers"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/9e1c7c894ee96f796d7432f284cf503e","name":"Anne Guedon","url":"https:\/\/www.satt.fr\/en\/author\/anne\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/20942","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=20942"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/20942\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/20903"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=20942"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=20942"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=20942"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}